Germany · Delayed Price · Currency is EUR MedMira Statistics
Total Valuation
MedMira has a market cap or net worth of EUR 30.39 million. The enterprise value is 40.95 million.
| Market Cap | 30.39M |
| Enterprise Value | 40.95M |
Important Dates
The last earnings date was Monday, December 29, 2025.
| Earnings Date | Dec 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 701.73M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | n/a |
| Float | 209.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 210.82 |
| PB Ratio | -2.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -16.40 |
| EV / Sales | 284.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -27.49 |
Financial Position
The company has a current ratio of 0.06
| Current Ratio | 0.06 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -7.09 |
| Interest Coverage | -2.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -45.47% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 14.94% |
| Revenue Per Employee | 2,772 |
| Profits Per Employee | -48,031 |
| Employee Count | 52 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 4.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.73% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -47.73% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 53.25 |
| Average Volume (20 Days) | 1,250 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedMira had revenue of EUR 144,148 and -2.50 million in losses. Loss per share was -0.00.
| Revenue | 144,148 |
| Gross Profit | -391,565 |
| Operating Income | -1.93M |
| Pretax Income | -2.50M |
| Net Income | -2.50M |
| EBITDA | -1.91M |
| EBIT | -1.93M |
| Loss Per Share | -0.00 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 10.56M |
| Net Cash | -10.56M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -14.46M |
| Book Value Per Share | -0.02 |
| Working Capital | -14.18M |
Cash Flow
In the last 12 months, operating cash flow was -1.49 million and capital expenditures -3,321, giving a free cash flow of -1.49 million.
| Operating Cash Flow | -1.49M |
| Capital Expenditures | -3,321 |
| Free Cash Flow | -1.49M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -271.64% |
| Operating Margin | -1,340.83% |
| Pretax Margin | -1,732.66% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MedMira does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | -0.11% |
| Earnings Yield | -8.22% |
| FCF Yield | -4.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MedMira has an Altman Z-Score of -50.52 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -50.52 |
| Piotroski F-Score | 2 |